Makes medical supplies and devices for hospitals, clinics and pharmaceutical companies, including drug-delivery and medication-management systems.
10-K for FY2025, filed Nov 25, 2025BD Medical produces a broad array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of…View ↗
Peripheral intravenous (“IV”) catheters (conventional, safety); advanced peripheral catheters (guidewire assisted peripherally inserted…View ↗
IV medication safety and infusion therapy delivery systems, including infusion pumps, dedicated disposables, and IV fluids; medication…View ↗
Prefillable drug delivery systems - prefillable syringes, safety, shielding and self-injection systems and support services (combination…View ↗
BD mainly sells products, with payment generally tied to shipment or delivery; complex equipment installations are paid for after customer acceptance. It also earns revenue from service arrangements over their contract terms.
10-K for FY2025, filed Nov 25, 2025
FY2025 revenue by reportable segment ↗$21.8B
10-K for FY2025, filed Nov 25, 2025
$21.8B ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Medical
Sold outright
10-K for FY2025, filed Nov 25, 2025 |
52%
FY2022: 47%
|
Medical, FY2025
$11.5B Sources
|
Sold outright |
|
Life Sciences
Sold outright
10-K for FY2025, filed Nov 25, 2025 |
24%
FY2022: 29%
|
Life Sciences, FY2025
$5.2B Sources
|
Sold outright |
|
Interventional
Sold outright
10-K for FY2025, filed Nov 25, 2025 |
24%
FY2022: 24%
|
Interventional, FY2025
$5.2B Sources
|
Sold outright |
Hospitals, clinics, laboratories, pharmaceutical companies and healthcare professionals buy BD products. BD sells through independent distributors and directly to end users through BD and independent sales representatives.
10-K for FY2025, filed Nov 25, 2025Medical produces a broad array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of…View ↗
Life Sciences provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to…View ↗
Interventional provides vascular, urology, oncology and surgical specialty products that are intended to be used once and then discarded or…View ↗
Distribution of products is primarily through independent distribution channels, and directly to end-users by BD and independent sales…View ↗
Yes. It kept 8 cents of every revenue dollar as net income in FY2025 and turned 12 cents into free cash flow.
8-K, filed Aug 6, 2026
The company updates its full year fiscal 2026 guidance as follows; expects revenue growth toward the high end of its range and raises the…View ↗
8-K, filed Feb 9, 2026
In connection with the transaction, BD shareholders will receive approximately 0.135 shares of Waters common stock for each share of BD…View ↗
Growing. Revenue grew 14% in 4 years, from $19.1B in FY2021 to $21.8B in FY2025, about 3% a year.
Patient monitoring added
BD added advanced patient monitoring systems to Medical, including systems that measure heart function and fluid status in surgical and intensive-care settings.
10-K for FY2025, filed Nov 25, 2025Advanced Patient MonitoringView ↗
Advanced hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care…View ↗
On September 3, 2024, BD completed the acquisition of Edwards Lifesciences’ Critical Care product group, which was renamed as BD Advanced…View ↗
Surgical Instrumentation sold
BD sold its Surgical Instrumentation platform; the older report listed surgical and laparoscopic instruments in Surgery, while the latest describes Surgery products without that platform.
10-K for FY2022, filed Nov 22, 2022 10-K for FY2025, filed Nov 25, 2025
Loading...